Investment in digital health is growing rapidly and has cumulatively reached $15.5bn in the US alone. However, much of this growth has been characterized by fragmentation for pharmaceutical companies. Despite iOS and Android hosting over 165,000 health apps, more than 48% of pharmaceutical company published apps do not have a single user review. It is little wonder, therefore, that a recent study has highlighted that only 13% of pharmaceutical leaders are satisfied with their current digital activities.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?